HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juan L Vivero-Escoto Selected Research

Small Interfering RNA (siRNA)

9/2020Combination of Nucleic Acid and Mesoporous Silica Nanoparticles: Optimization and Therapeutic Performance In Vitro.
12/2019Nanoparticle mediated silencing of tenascin C in hepatic stellate cells: effect on inflammatory gene expression and cell migration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Juan L Vivero-Escoto Research Topics

Disease

11Neoplasms (Cancer)
04/2024 - 01/2015
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 12/2011
3Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2015 - 02/2010
2Melanoma (Melanoma, Malignant)
09/2021 - 09/2020
2Breast Neoplasms (Breast Cancer)
09/2020 - 12/2016
2Triple Negative Breast Neoplasms
09/2020 - 04/2019
1COVID-19
05/2023
1Fibrosis (Cirrhosis)
12/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2019
1Liver Diseases (Liver Disease)
12/2019
1Communicable Diseases (Infectious Diseases)
01/2019
1Adenocarcinoma
12/2016
1Phototoxic Dermatitis (Phototoxicity)
12/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015
1Colonic Neoplasms (Colon Cancer)
12/2011

Drug/Important Bio-Agent (IBA)

6Silicon Dioxide (Silica)FDA LinkGeneric
04/2024 - 02/2010
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2015
4polysilsesquioxaneIBA
09/2021 - 01/2015
31-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2023 - 10/2020
2GemcitabineFDA Link
01/2022 - 01/2022
2PorphyrinsIBA
10/2020 - 12/2015
2Small Interfering RNA (siRNA)IBA
09/2020 - 12/2019
2Proteins (Proteins, Gene)FDA Link
12/2019 - 12/2016
2ProdrugsIBA
01/2016 - 01/2015
2Contrast MediaIBA
10/2013 - 12/2011
1Cancer VaccinesIBA
04/2024
1Therapeutic UsesIBA
04/2024
1LipidsIBA
05/2023
1cyclopamineIBA
01/2022
1Photosensitizing Agents (Photosensitizers)IBA
09/2021
1protoporphyrin IXIBA
09/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2020
1Green Fluorescent ProteinsIBA
09/2020
1Extracellular Matrix ProteinsIBA
12/2019
1TenascinIBA
12/2019
1Nucleic AcidsIBA
04/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Glycoproteins (Glycoprotein)IBA
12/2016
1Mucin-1 (CA 15-3 Antigen)IBA
12/2016
1Coloring Agents (Dyes)IBA
12/2016
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2016
1tetracarboxyphenylporphineIBA
12/2015
1aluminum chloride phthalocyanineIBA
12/2015
13- (4,5- dimethylthiazol- 2- yl)- 5- (3- carboxymethoxyphenyl)- 2- (4- sulfophenyl)- 2H- tetrazoliumIBA
12/2015
1PolymersIBA
01/2015
1Intercalating AgentsIBA
02/2010
1phenanthridiniumIBA
02/2010
1OligonucleotidesIBA
02/2010

Therapy/Procedure

4Therapeutics
04/2024 - 12/2015
3Drug Therapy (Chemotherapy)
09/2020 - 12/2015
2Photochemotherapy (Photodynamic Therapy)
09/2021 - 12/2015
2Lasers (Laser)
12/2015 - 12/2015
1Cell- and Tissue-Based Therapy (Cell Therapy)
04/2024
1Immunotherapy
04/2024
1Combination Drug Therapy (Combination Chemotherapy)
01/2022
1Phototherapy (Light Therapy)
04/2019
1Chemoradiotherapy
01/2015